Vimarsana
Biggest News Aggregation in the World

Page 17 - Philipp Mathieu News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Philipp Mathieu. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Philipp Mathieu Today - Breaking & Trending Today

Immunovia invited to the 42nd Annual Cowen Health Care Conference - Vimarsana News

Immunovia invited to the 42nd Annual Cowen Health Care Conference

/PRNewswire/ -- Immunovia will participate in the Cowen 42nd Annual Health Care Virtual Conference on March 9, 2022. Philipp Mathieu, Acting CEO and President,...

IMMray™ PanCan-d - peer-reviewed, blinded validation study now published in Clinical and Translational Gastroenterology - Vimarsana News

IMMray™ PanCan-d - peer-reviewed, blinded validation study now published in Clinical and Translational Gastroenterology

/PRNewswire/ -- Immunovia AB (publ) announces that the peer-reviewed, blinded study to independently validate the clinical performance of IMMray™ PanCan-d has...

Immunovia AB: Immunovia Publishes Full Year Report 2021 - Vimarsana News

Immunovia AB: Immunovia Publishes Full Year Report 2021

LUND, SWEDEN, Feb. 17, 2022 /PRNewswire/ -- Immunovia has today published its full year report 2021. It is available on Immunovia's website. First product launched in US, well positioned

Immunovia Publishes Full Year Report 2021 - Vimarsana News

Immunovia Publishes Full Year Report 2021

/PRNewswire/ -- Immunovia has today published its full year report 2021. It is available on Immunovia's website. First product launched in US, well positioned...

IMMray™ PanCan-d - peer-reviewed, blinded validation study now published in Clinical and Translational Gastroenterology - Vimarsana News

IMMray™ PanCan-d - peer-reviewed, blinded validation study now published in Clinical and Translational Gastroenterology

/PRNewswire/ -- Immunovia AB (publ) announces that the peer-reviewed, blinded study to independently validate the clinical performance of IMMray™ PanCan-d has...